Exchange: NASDAQ·Updated 04:10 PM EDT
PASG logo

PASGPassage Bio Inc

$4.57
$0.05
(1.08%)
Today
Closed $4.57
$0.00
(0.00%)
After Hours
Reported EarningsMar 3
Mkt Cap$14.84M
Vol15,029.00
News
all
press releases
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CRNX, SLP, NCSM, and PASG
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CRNX, SLP, NCSM, and PASG $HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CRNX, SLP, NCSM, and PASG PR Newswire NEW YORK, July 23, 2026 NEW YORK, July 23, 2026 /PRNewswire...
PR Newswire
More News
SPRY, PASG, BOXL: Why These Stocks Plunged Double Digits In After-Hours Trading Today
The after-hours decline was driven by concerns over trading activity, business performance and company restructuring plans.
Stocktwits
PASG Stock Slumps 16% After-Hours — What’s Driving The Selloff?
Passage Bio said on Wednesday that it will merge with privately held Remix Therapeutics.
Stocktwits
Passage Bio Inc (PASG) Stock: Should You Buy the Dip For 125% Upside?
Passage Bio Inc (PASG) Stock: Should You Buy the Dip For 125% Upside...
Yahoo! Finance: News
This Mohawk Industries Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Tuesday
Wall Street analysts changed outlook for top names, including downgrading Mohawk Industries and Passage Bio. See analyst ratings for these stocks.read more...
Benzinga
Passage Bio (NASDAQ:PASG) CEO Sells $75,161.44 in Stock
Passage Bio, Inc. (NASDAQ:PASG - Get Free Report) CEO William Chou sold 4,076 shares of the business's stock in a transaction dated Thursday, January 8th. The shares were sold at an average price of...
MarketBeat
Insider Selling: Passage Bio (NASDAQ:PASG) CEO Sells $75,161.44 in Stock
Passage Bio, Inc. (NASDAQ:PASG - Get Free Report) CEO William Chou sold 4,076 shares of the firm's stock in a transaction dated Thursday, January 8th. The shares were sold at an average price of...
MarketBeat
PASSAGE BIO, INC. Q3 Loss Decreases, Beats Estimates
(RTTNews) - PASSAGE BIO, INC. (PASG) announced Loss for third quarter that decreased from the same period last year and beat the Street estimates...
Nasdaq News: Markets
Wall Street Analysts Think Passage Bio (PASG) Could Surge 731%: Read This Before Placing a Bet
The mean of analysts' price targets for Passage Bio (PASG) points to a 731% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks
Wall Street Analysts Believe Passage Bio (PASG) Could Rally 1415.15%: Here's is How to Trade
The mean of analysts' price targets for Passage Bio (PASG) points to a 1415.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks
<
1
2
>

Advertisement|Remove ads.